publication venue for
- CD274 (PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract.. 7. 2022
- The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum.. 5. 2019
- Clinical Trials Corner.. 4. 2018
- Clinical Trials Corner.. 4. 2018
- Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients.. 4. 2018
- Clinical Trials Corner.. 4. 2018
- Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.. 4. 2018
- Clinical Trials Corner.. 4. 2018
- Clinical Trials Corner.. 3. 2017
- Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.. 3. 2017
- High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.. 3. 2017
- Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.. 3. 2017
- Clinical Trials Corner.. 3. 2017
- Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063).. 3. 2017
- Micropapillary Bladder Cancer: Insights from the National Cancer Database.. 2. 2016
- Clinical Trials Corner.. 2. 2016
- Clinical Trials Corner.. 2. 2016
- Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank.. 2. 2016
- Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.. 2. 2016
- Clinical Trials Corner.. 2. 2016
- Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study.. 2. 2016
- Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma.. 2. 2016